Kishina et al. 9 reported that aliskiren reduced hepatic steatosis in Shionogi-ob/ob mice, however the underlying mechanism to reduce steatosis was not elucidated and insulin resistance was not measured. This evidence concerns the gene INS and fatty liver disease.